Ritanserin

N/A

Report date: 2022/05/12 17:24:49
NME

Base Information

Drug NameRitanserin
Drug Alias Name利坦色林R-55667R 55667
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsAnxietyDepressionCocaine-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative MedicineUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsAnxietyDepressionCocaine-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A